Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel, ...

On Tuesday, Beyond Inc (BYON) stock saw a modest uptick, ending the day at $10.34 which represents a slight increase of $0.17 or 1.67% from the prior close of $10.17. The stock opened at $10.2 and ...

Fintel reports that on October 11, 2024, Maxim Group initiated coverage of Cheche Group (NasdaqCM:CCG) with a Buy ...

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that Brian M.

Fintel reports that on October 9, 2024, Maxim Group downgraded their outlook for Virpax Pharmaceuticals (NasdaqCM:VRPX) from ...

Maxim Group analyst Naz Rahman maintained a Buy rating on Neurosense Therapeutics Ltd. (NRSN – Research Report) yesterday. The ...

Maxim Group analyst Naz Rahman reiterated a Buy rating on NexGel Inc (NXGL – Research Report) yesterday. The company’s shares ...

Azitra to present at the 2024 Maxim Healthcare Virtual Summit, highlighting advancements in precision dermatology therapies.

NEW YORK, NY/ OCTOBER 11, 2024 / B2i Digital, Inc. continues to support Maxim Group's virtual conference series with its role as a Marketing Partner for the 2024 Healthcare Virtual Summit. The event ...

Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on developing innovative therapies for ...

PM ETOCALA, Fla., Oct. 09, 2024 (GLOBE NEWSWIRE) -- (NYSE American: AIM) (“AIM” or the “Company”), announced today that Tom ...

Maxim Group 2024 Healthcare Virtual Summit B2i Digital Featured Conference: Maxim 2024 Healthcare Virtual Summit B2i Digital to ...